PUBLIC COMPANY
save$CATXPerspective Therapeutics, Inc.
$CATXSeattle, WA, USupdated 4mo ago
community read0 votes
pipeline
3
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
3Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Lead-212 PSV359 Therapy for Patients With Solid Tumors
- phase2MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
- phase2Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- phase1Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that